Top 10 stocks for today – 28th March 2024

28 Mar 2024 , 08:18 AM

Top 10 stocks for today – 28th March 2024

Here are some of the stocks that may see significant price movement today.

Maruti Suzuki: The country’s largest automaker said that Partho Banerjee has been promoted to head of marketing and sales, effective April 1. He is now acting as the chief of services. Banerjee succeeded Shashank Srivastava, who was promoted from head of marketing and sales to member of the Executive Committee. Similarly, Tarun Aggarwal has been appointed head of engineering. Tarun succeeded CV Raman, who has also been promoted to the Member Executive Committee.

Dr Reddy’s Laboratories: The company has formed an exclusive distribution collaboration with Sanofi Healthcare India to market and sell Sanofi’s vaccine products, including pediatric and adult vaccinations, throughout India.

JSW Energy: The power business announced that the board of directors would meet on April 2 to explore raising money by the issuing of qualifying securities of the firm via private offers, preferential allocation basis, qualified institution placement, or any other means.

Jio Financial Services: Jio Financial presently has a 76.98% interest in Jio Payments Bank (JPBL). JPBL is a joint venture between Jio Financial and State Bank of India. Jio Financial has purchased 40 lakh equity shares of JPBL at ₹10 apiece for cash at par, totaling ₹4 Crore for its business purposes. After the acquisition is completed, Jio Financial’s stake in JPBL will rise to 77.25%.

Tata Elxsi: The Tata Group has established a partnership with Drager, a worldwide leader in medical and safety technologies, to drive critical care innovation in India. Drager is increasing its R&D footprint by opening a new offshore development centre (ODC) at Tata Elxsi’s site in Pune.

Biocon: The biopharmaceutical business has got permission from the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) for its formulation, Liraglutide, which was filed through its European partner, Zentiva. Liraglutide is a drug-device combination formulation used to treat Type 2 diabetes mellitus, a condition in which the body does not manufacture or respond appropriately to insulin, resulting in excessively high blood sugar (glucose) levels.

Life Insurance Corporation of India: The Corporation has filed an appeal with the Commissioner (Appeals), Mumbai, against the decision issued by the Deputy Commissioner of State Tax, Mumbai, demanding GST of ₹365.02 Crore for FY18, interest of ₹404.77 Crore, and a penalty of ₹36.50 Crore. LIC has filed an appeal before the Commissioner (Appeals), Ahmedabad, challenging the Additional Commissioner, Central Goods and Service Tax, Gandhinagar’s decision for a GST demand of ₹191.02 Crore for FY18 and FY19, as well as interest and penalty of ₹191.02 Crore.

Zydus Lifesciences: The US Food and Drug Administration (USFDA) examined the SEZ Onco Injectable manufacturing factory in Ahmedabad. This cGMP USFDA inspection took place from March 18 to 27. The US health regulator concluded the examination with four observations. There were no observations about data integrity.

NHPC: The Board of Directors has approved the company’s plan to raise debt up to ₹6,100 Crore in FY25 through the sale of non-convertible corporate bonds in one or more series or tranches on a private placement basis, as well as the funding of term loans or external commercial borrowings. Furthermore, the board has given its in-principle permission for the closure of Loktak Downstream Hydroelectric Corporation.

Cyient: The engineering and technology solutions firm has entered into a strategic collaboration with Deutsche Aircraft, a German original equipment manufacturer. The businesses will collaborate on the detailed design for manufacture (DFM) of the rear fuselage part of the 40-seater D328eco regional turboprop aircraft.

For feedback and suggestions, write to us at [e-mail]